Last week in GLP1 (2025/09/22)
Here’s what happened last week in the GLP1 ecosystem:
📊 Study: Wegovy pill shows 16.6% weight loss
📑 GLP1s could reduce all-cause mortality by up to 6% by 2045
Read more
A new study on GLP1s eye risk
One of the biggest emerging risks of using GLP1s has been the link between GLP1s and vision loss — whether via NAION or macular degeneration. We’ve covered this before: The link between Semaglutide & vision loss (NAION)How deep is the link between GLP1s and possible vision loss? We examine
Last week in GLP1 (2025/09/15)
Here’s what happened last week in the GLP1 ecosystem: 🧑⚖️ Lawsuits over the negative side effects of GLP1s 🌐 The WHO is building a guideline for GLP1 use and requesting comments 🎭 Celebrity endorsements continue: Andy Cohen reveals use of GLP1s for weight management 🚨 GLP1 is now being used in SMS scams
Massive GLP1 use in Silicon Valley survey
We mostly hear of increased adoption of GLP1s in the mainstream — entertainers and public figures being quizzed on whether they use it or not, spectacular transformations for patients who have found a GLP1 that works for them, etc. Silicon Valley and those that like to experiment or “bio-hack” were very
An under-reported negative side effect: CVS
Keeping track of negative side effects of GLP1s is just as important (if not more important) than keeping track of positive side effects. Cyclic Vomiting Syndrome is a *rare* negative side effect that doesn’t come up in the research very often, but after hearing anecdotal reports of this side